Our findings reveal that calycosin exerts its anticancer effects by acting on SMAD3 through the NOTCH signaling pathway in monocytes/macrophages, highlighting the intricate interplay between tumor cells and the immune microenvironment in LUAD pathogenesis. This evidence concerns the gene SMAD3 and neoplasm.